脑小血管病患者认知与运动症状的长期纵向病程
本研究基于拉德堡德大学奈梅亨弥散张量与磁共振队列(前瞻性队列)的脑小血管病患者,随访中位12.8年(四分位距10.2-15.3),501例中132例(26.3%)发生帕金森综合征、痴呆或两者兼有;在诊断前数年,不同转归组已呈现可区分的运动与认知功能下降轨迹。
要点
- 501例脑小血管病患者中132例(26.3%)在中位12.8年随访中发生帕金森综合征、痴呆或两者兼有。
- 发生帕金森综合征者统一帕金森病评定量表运动部分评分年增22%(95%CI 18%-27%),高于对照组的16%(95%CI 14%-18%)。
- 各转归组执行功能Z评分年下降均快于对照组,其中帕金森综合征合并痴呆组下降最快。
核心结论
- 脑小血管病患者在帕金森综合征和痴呆诊断前数年即可见临床标志物的特征性恶化模式,有助于早期识别高风险患者。
研究设计与样本
- 研究为拉德堡德大学奈梅亨弥散张量与磁共振队列研究,属前瞻性队列,纳入脑小血管病患者501例。
- 帕金森综合征依据英国帕金森病学会脑库标准诊断,痴呆依据《精神障碍诊断与统计手册》第五版重性神经认知障碍标准诊断。
- 采用线性混合效应分析与广义线性混合效应分析研究运动与认知任务的纵向病程。
主要发现
- 中位随访12.8年(四分位距10.2-15.3)后,501例中132例(26.3%)发生帕金森综合征、痴呆或两者兼有。
- 发生帕金森综合征者统一帕金森病评定量表运动部分评分年增22%(95%CI 18%-27%),显著高于对照组的16%(95%CI 14%-18%),主要因运动迟缓和姿势步态障碍陡增。
- 合并痴呆者起立行走计时测试时间年增0.73秒(95%CI 0.58-0.87),显著高于对照组的0.20秒/年(95%CI 0.16-0.23)。
- 执行功能Z评分年下降:帕金森综合征组-0.07(95%CI -0.10至-0.05)、痴呆组-0.09(95%CI -0.11至-0.08)、两者兼有组-0.11(95%CI -0.14至-0.08),均快于对照组的0.07(95%CI -0.10至-0.05)。
临床怎么用
- 作者认为,上述知识有助于早期识别发生帕金森综合征和痴呆高风险的脑小血管病患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients with cerebral small vessel disease (SVD) show a heterogenous clinical course. The aim of the current study was to investigate the longitudinal course of cognitive and motor function in patients who developed parkinsonism, dementia, both, or none. METHODS: Participants were from the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort study, a prospective cohort of patients with SVD. Parkinsonism and dementia were, respectively, diagnosed according to the UK Parkinson's Disease Society brain bank criteria and the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for major neurocognitive disorder. Linear and generalized linear mixed-effect analyses were used to study the longitudinal course of motor and cognitive tasks. RESULTS: After a median follow-up of 12.8 years (interquartile range 10.2-15.3), 132 of 501 (26.3%) participants developed parkinsonism, dementia, or both. Years before diagnosis of these disorders, participants showed distinct clinical trajectories from those who developed none: Participant who developed parkinsonism had an annual percentage of 22% (95% CI 18%-27%) increase in motor part of the Unified Parkinson's Disease Rating Scale score. This was significantly higher than the 16% (95% CI 14%-18%) of controls, mainly because of a steep increase in bradykinesia and posture and gait disturbances. When they developed dementia as well, the increase in Timed Up and Go Test time of 0.73 seconds per year (95% CI 0.58-0.87) was significantly higher than the 0.20 seconds per year increase (95% CI 0.16-0.23) of controls. All groups, including the participants who developed parkinsonism without dementia, showed a faster decline in executive function compared with controls: Annual decline in Z-score was -0.07 (95% CI -0.10 to -0.05), -0.09 (95% CI -0.11 to -0.08), and -0.11 (95% CI -0.14 to -0.08) for participants who developed, respectively, parkinsonism, dementia, and both parkinsonism and dementia. These declines were all significantly faster than the annual decline in Z-score of 0.07 (95% CI -0.10 to -0.05) of controls. DISCUSSION: A distinct pattern in deterioration of clinical markers is visible in patients with SVD, years before the diagnosis of parkinsonism and dementia. This knowledge aids early identification of patients with a high risk of developing these disorders.
引用
- Bergkamp MI, Jacob MA, Cai M, et al. Long-Term Longitudinal Course of Cognitive and Motor Symptoms in Patients With Cerebral Small Vessel Disease. Neurology. 2024. PMID: 38382000. doi:10.1212/WNL.0000000000209148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。